Quantitative transcriptome‐based analysis predicts a combination therapy for severe haemophilia B: A case report-Reference-Cited by-同舟云学术

Quantitative transcriptome‐based analysis predicts a combination therapy for severe haemophilia B: A case report

Published:2023-12-26 Issue: Volume: Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Zhang Jundong¹^ORCID,Chen Haoran²,Shi Lei³,Ma Yanping⁴,Zhi Peng⁵⁶,Li Hongyi⁵,Zhang Haojun⁷,Geng Jie⁷,Zhang Li Zhong⁷,Jing Yu⁸^ORCID,Lu Xuechun¹⁹^ORCID

Affiliation:

1. Department of Hematology Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital Beijing China

2. School of Management Shanxi Medical University Taiyuan China

3. Senior Department of Infectious Diseases, the Fifth Medical Center & National Clinical Research Center for Infectious Diseases Chinese PLA General Hospital Beijing China

4. Department of Hematology The Second Hospital of Shanxi Medical University Taiyuan Shanxi China

5. Medical School of Chinese PLA Beijing China

6. Medical Big Data Research Center Chinese PLA General Hospital Beijing China

7. Basic Medicine College, Shanxi Medical University Taiyuan China

8. Department of Hematology Fifth Medical Center, Chinese PLA General Hospital Beijing China

9. Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Nephrology Institute of the Chinese People's Liberation Army, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases Beijing Key Laboratory of Kidney Disease Research Beijing China

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.19261

Reference8 articles.

1. Another Victory for Patients with Hemophilia

2. Clinical severity of haemophilia A: does the classification of the 1950s still stand?

3. Emicizumab, a bispecific antibody recognizing coagulation factors IX and X: how does it actually compare to factor VIII?

4. Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial

5. Moderate-intensity aerobic exercise vs desmopressin in adolescent males with mild hemophilia A: a randomized trial